Physician profile
Michelle Giannone
NPI 1578790671
$1,995.95
in general payments reported to CMS, 2019-2025
21 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.19 · 2020: $236 · 2021: $175 · 2022: $173 · 2023: $412 · 2024: $637 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,225 · Education: $99.00 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.54 |
| Education | $99.00 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $318.71 | 2023-2025 | Veozah |
| Abbvie INC. | $250.50 | 2021-2024 | |
| Avion Pharmaceuticals | $244.18 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $136.85 | 2021-2025 | |
| Biogen, INC. | $124.90 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $118.61 | 2024 | |
| Evofem Biosciences, INC. | $83.12 | 2020-2025 | Solosec, Phexx, Phexxi |
| Daiichi Sankyo INC. | $83.08 | 2022-2023 | Injectafer |
| Sumitomo Pharma America, INC. | $82.59 | 2024-2025 | Myfembree |
| Therapeuticsmd, INC. | $79.39 | 2020 | |
| Millicent US INC | $70.14 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Pfizer INC. | $57.06 | 2023-2024 | |
| Coopersurgical, INC. | $48.07 | 2019-2023 | Summit Doppler |
| Exact Sciences Corporation | $47.62 | 2023 | Cologuard Collection Kit |
| Bausch Health US, LLC | $44.48 | 2023 | Wellbutrin, Aplenzin |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $41.53 | 2021-2022 | |
| Medtronic, INC. | $38.11 | 2024 | Truclear |
| Sanofi Pasteur INC. | $37.33 | 2025 | |
| Amgen INC. | $35.96 | 2020-2025 | Evenity |
| Scynexis, INC. | $32.94 | 2022 | |
| Exeltis, USA INC. | $20.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Giannone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.